ClearBridge Investments
ACOR

ClearBridge Investments’s Acorda Therapeutics ACOR Stock Holding History

ClearBridge Investments’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4
Closed -$1K – 1109
2019
Q4 		$1K Hold
4
– – ﹤0.01% 1086
2019
Q3 		$1K Hold
4
– – ﹤0.01% 1105
2019
Q2 		$4K Sell
4
-6,555
-100% -$8.06M ﹤0.01% 1048
2019
Q1 		$10.5M Buy
6,559
+23
+0.4% +$41.4K 0.01% 525
2018
Q4 		$12.2M Buy
6,536
+23
+0.4% +$50K 0.01% 487
2018
Q3 		$15.4M Hold
6,513
– – 0.01% 479
2018
Q2 		$22.4M Buy
6,513
+32
+0.5% +$98K 0.02% 405
2018
Q1 		$18.4M Sell
6,481
-1,432
-18% -$4.29M 0.02% 413
2017
Q4 		$20.4M Buy
7,913
+2
+0% +$5.69K 0.02% 416
2017
Q3 		$22.4M Buy
7,911
+3
+0% +$7.9K 0.02% 409
2017
Q2 		$18.7M Buy
7,908
+30
+0.4% +$59.4K 0.02% 434
2017
Q1 		$19.9M Buy
7,878
+13
+0.2% +$37.4K 0.02% 423
2016
Q4 		$17.7M Sell
7,865
-10
-0.1% -$23.8K 0.02% 422
2016
Q3 		$19.7M Buy
7,875
+2
+0% +$5.97K 0.02% 412
2016
Q2 		$24.1M Buy
7,873
+33
+0.4% +$107K 0.03% 387
2016
Q1 		$24.9M Sell
7,840
-113
-1% -$469K 0.03% 376
2015
Q4 		$40.8M Sell
7,953
-28
-0.4% -$122K 0.05% 306
2015
Q3 		$25.4M Sell
7,981
-293
-4% -$1.14M 0.03% 377
2015
Q2 		$33.1M Sell
8,274
-73
-0.9% -$282K 0.04% 360
2015
Q1 		$33.3M Buy
8,347
+13
+0.2% +$59.5K 0.03% 359
2014
Q4 		$40.9M Sell
8,334
-61
-0.7% -$262K 0.04% 329
2014
Q3 		$34.1M Buy
8,395
+52
+0.6% +$195K 0.04% 353
2014
Q2 		$33.7M Buy
8,343
+28
+0.3% +$114K 0.04% 357
2014
Q1 		$37.8M Buy
8,315
+458
+6% +$1.85M 0.04% 328
2013
Q4 		$27.5M Buy
7,857
+896
+13% +$3.49M 0.03% 381
2013
Q3 		$28.6M Buy
6,961
+1,839
+36% +$7.92M 0.04% 343
2013
Q2 		$20.3M Buy
+5,122
New +$21.1M 0.03% 389

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments's ACOR Position: Q1 2020 in Review

ClearBridge Investments sold out of Acorda Therapeutics (ACOR) in Q1 2020, closing a stake of 4 shares — an estimated $1K sold.

ClearBridge Investments first reported a position in ACOR in Q2 2013 and held it in 27 quarters. The position peaked at $40.9M in Q4 2014. 106 funds tracked by Wall St. Rank hold ACOR as of Q1 2020.

  • ClearBridge Investments reported no remaining Acorda Therapeutics position as of Q1 2020 after selling out during the quarter.
  • ClearBridge Investments sold 4 Acorda Therapeutics shares in Q1 2020, an estimated $1K.
  • ClearBridge Investments first reported a position in Acorda Therapeutics in Q2 2013 and held it in 27 quarters.
  • ClearBridge Investments's Acorda Therapeutics position peaked at $40.9M in Q4 2014.
  • 106 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2020.

Based on ClearBridge Investments's 13F filing for Q1 2020, filed 15 May 2020.